EndoChoice (GI) Stock Price, News & Analysis

Company Overview

EndoChoice Holdings, Inc. is a medical device company. The Company is focused on designing and commercializing a platform of products and services for gastrointestinal (GI) caregivers. The Company offers a range of products and services that span single-use devices and infection control products, pathology and imaging systems. The Company's products are used in colonoscopy and procedures of the upper GI tract, including esophagogastroduodenoscopy (EGD). The Company's imaging products include Fuse system, EndoCart, and Endoscope repair and maintenance. The Company's single-use therapeutic devices include Neptune injection needle, Boa polypectomy snare, Rescue retrieval devices, Blox bite block, TrapEase polyp traps, Hydra irrigation system, EndoGlide+, Compliance EndoKit, SafeStart, EndoKit, CinchPad and GI pathology. The Company serves over 2,500 GI departments that perform endoscopic procedures.

Key Stats

• Today's Range: $8.00 to $8.00
• 50-Day Range: N/A
• 52-Week Range: $3.64 to $9.47
• Volume: N/A
• Average Volume: 131,115 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

GI Stock Analysis - Frequently Asked Questions

How were EndoChoice's earnings last quarter?

EndoChoice Holdings Inc (NYSE:GI) issued its earnings results on Wednesday, May, 4th. The medical equipment provider reported ($0.68) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.55) by $0.13. EndoChoice's revenue for the quarter was up 10.2% on a year-over-year basis.

When did EndoChoice IPO?

EndoChoice (GI) raised $101 million in an initial public offering (IPO) on Friday, June 5th 2015. The company issued 6,300,000 shares at $15.00-$17.00 per share. J.P. Morgan, BofA Merrill Lynch, William Blair and Stifel served as the underwriters for the IPO.

What other stocks do shareholders of EndoChoice own?

Based on aggregate information from My MarketBeat watchlists, some other companies that EndoChoice investors own include Cognyte Software (CGNT), Butterfly Network (BFLY), Coeur Mining (CDE), Denison Mines (DNN), DarioHealth (DRIO), CarParts.com (PRTS) and Air Canada (AC).

Company Calendar

• Last Earnings: 5/04/2016
• Today: 5/27/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: N/A
• Industry: N/A
• Sub-Industry: N/A
• Current Symbol: NYSE:GI
• CIK: 1623919
• Web: www.endochoice.com
• Phone: N/A
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A